TODD STRATEGY GROUP

Lobbying for EMD SERONO INC. · Biopharmaceutical business.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Bills named in this filing 1

Lobbying activity 2

Pharmacy

Drug pricing policy. Implementation of Inflation Reduction Act of 2022. S.864 - HELP Copays Act.

Health Issues

PBM Reform. 340B Program. Supply chain. Issues pertaining to reproductive health and access and coverage of infertility treatments and care.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.